JPWO2007034843A1 - 多孔質基盤体とその製造方法並びに多孔質基盤体の使用方法 - Google Patents
多孔質基盤体とその製造方法並びに多孔質基盤体の使用方法 Download PDFInfo
- Publication number
- JPWO2007034843A1 JPWO2007034843A1 JP2007536538A JP2007536538A JPWO2007034843A1 JP WO2007034843 A1 JPWO2007034843 A1 JP WO2007034843A1 JP 2007536538 A JP2007536538 A JP 2007536538A JP 2007536538 A JP2007536538 A JP 2007536538A JP WO2007034843 A1 JPWO2007034843 A1 JP WO2007034843A1
- Authority
- JP
- Japan
- Prior art keywords
- porous
- porous substrate
- bioabsorbable
- cells
- substrate according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 107
- 238000000034 method Methods 0.000 title claims description 47
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 239000011148 porous material Substances 0.000 claims abstract description 65
- 238000010899 nucleation Methods 0.000 claims abstract description 27
- 239000012528 membrane Substances 0.000 claims abstract description 26
- 230000002093 peripheral effect Effects 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 113
- 229920005615 natural polymer Polymers 0.000 claims description 46
- 230000010261 cell growth Effects 0.000 claims description 41
- 239000003102 growth factor Substances 0.000 claims description 41
- 230000024245 cell differentiation Effects 0.000 claims description 39
- 229920001059 synthetic polymer Polymers 0.000 claims description 37
- 210000001612 chondrocyte Anatomy 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 14
- 210000000130 stem cell Anatomy 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000003475 lamination Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 45
- 210000001519 tissue Anatomy 0.000 description 35
- 229920000642 polymer Polymers 0.000 description 31
- 210000000845 cartilage Anatomy 0.000 description 23
- 239000000463 material Substances 0.000 description 22
- 239000002131 composite material Substances 0.000 description 19
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 18
- 239000007864 aqueous solution Substances 0.000 description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- 238000004132 cross linking Methods 0.000 description 17
- -1 porosity Substances 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 14
- 229920001577 copolymer Polymers 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 14
- 239000004677 Nylon Substances 0.000 description 13
- 239000003431 cross linking reagent Substances 0.000 description 13
- 229920001778 nylon Polymers 0.000 description 13
- 229920001436 collagen Polymers 0.000 description 12
- 239000010410 layer Substances 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 239000000515 collagen sponge Substances 0.000 description 11
- 239000004698 Polyethylene Substances 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 229920000573 polyethylene Polymers 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000004310 lactic acid Substances 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 210000000056 organ Anatomy 0.000 description 9
- 230000001172 regenerating effect Effects 0.000 description 8
- 238000010186 staining Methods 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 229920000954 Polyglycolide Polymers 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 7
- 239000004633 polyglycolic acid Substances 0.000 description 7
- 239000004626 polylactic acid Substances 0.000 description 7
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 210000001185 bone marrow Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 229920000747 poly(lactic acid) Polymers 0.000 description 6
- 229920001610 polycaprolactone Polymers 0.000 description 6
- 102000012422 Collagen Type I Human genes 0.000 description 5
- 108010022452 Collagen Type I Proteins 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000010097 foam moulding Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 230000017423 tissue regeneration Effects 0.000 description 5
- 238000002054 transplantation Methods 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
- 102000057297 Pepsin A Human genes 0.000 description 4
- 108090000284 Pepsin A Proteins 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000635 electron micrograph Methods 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 210000003041 ligament Anatomy 0.000 description 4
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- 229940111202 pepsin Drugs 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 210000002798 bone marrow cell Anatomy 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000004088 foaming agent Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000010030 laminating Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 229950003937 tolonium Drugs 0.000 description 3
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 3
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 2
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 108010045569 atelocollagen Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 238000012407 engineering method Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 102000016284 Aggrecans Human genes 0.000 description 1
- 108010067219 Aggrecans Proteins 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000600434 Homo sapiens Putative uncharacterized protein encoded by MIR7-3HG Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102100037401 Putative uncharacterized protein encoded by MIR7-3HG Human genes 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000011173 biocomposite Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002648 chondrogenic effect Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 210000005009 osteogenic cell Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003594 spinal ganglia Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
また、本発明は、良好な生体親和性を有し、隣接する幾つかの組織におけるそれぞれの組織の再生に適合するようにできる多孔質基盤体とその製造方法並びに多孔質基盤体の使用方法を提供することをも課題としている。
(1)細胞の播種用孔を有する多孔質基盤体であって、細胞の播種用孔を有する多孔質な主体の外周面に前記細胞よりも小さい孔からなる多孔質膜を配設してなることを特徴とする多孔質基盤体。
(2)上記第(1)の多孔質基盤体において、その主体が、フレーム状の骨格を有することを特徴とする多孔質基盤体。
(3)上記(1)の多孔質基盤体において、その主体が、カゴ状の骨格を有することを特徴とする多孔質基盤体。
(4)上記(1)から(3)のいずれかの多孔質基盤体において、その多孔質膜は、生体吸収性物質又は生体非吸収性物質であることを特徴とする多孔質基盤体。
(5)上記(1)から(4)のいずれかの多孔質基盤体において、その多孔質膜上に、さらに膜状多孔質体を積層してなることを特徴とする多孔質基盤体。
(6)上記(5)の多孔質基盤体において、その膜状多孔質体が複数層繰り返して配設され、多層化されていることを特徴とする多孔質基盤体。
(7)上記(3)の多孔質基盤体において、そのカゴ状主体中に、さらに多孔質物質を充填してなることを特徴とする多孔質基盤体。
(8)上記(7)の多孔質基盤体において、その多孔質物質は、生体吸収性物質であることを特徴とする多孔質基盤体。
(9)上記(4)又は(8)の多孔質基盤体において、その生体吸収性物質は、少なくとも生体吸収性合成高分子、生体吸収性天然高分子、細胞成長因子、細胞分化制御因子およびこれらの誘導体からなる群より選ばれる少なくとも1種よりなることを特徴とする多孔質基盤体。
(10)上記(1)から(8)のいずれかの多孔質基盤体において、互いに異なる性質を有する層からなる複層構造を有することを特徴とする多孔質基盤体。
(11)上記(10)の多孔質基盤体において、積層、包接、被覆、粒状もしくは塊状の接触、立体もしくは平面域のパターン接触、あるいはこれらの2種以上の組合せにより積層化されていることを特徴とする多孔質基盤体。
(12)上記(10)又は(11)の多孔質基盤体において、複層構造を構成する各層は、組成、空隙率や孔の大きさや孔の連通性などの多孔質構造、および力学的性質のうちの少なくとも1種が互いに異なることを特徴とする多孔質基盤体。
(13)上記(1)から(12)のいずれかの多孔質基盤体において、その主体が、生体吸収性合成高分子、生体吸収性天然高分子、細胞成長因子、細胞分化制御因子、およびこれらの誘導体からなる群から選ばれる少なくとも1種よりなることを特徴とする多孔質基盤体。
(14)上記(10)から(12)のいずれかの多孔質基盤体において、複層構造の少くとも1層は、生体吸収性合成高分子、生体吸収性天然高分子、細胞成長因子、細胞分化制御因子、およびこれらの誘導体からなる群から選ばれる少なくとも1種よりなることを特徴とする多孔質基盤体。
(15)上記(1)から(14)のいずれかの多孔質基盤体の製造方法であって、主体に骨格構造を有するものを用い、当該骨格構造の表面に多孔質膜を積層することを特徴とする多孔質基盤体の製造方法。
(16)上記(1)から(14)のいずれかの多孔質基盤体の使用方法であって、その主体内に、軟骨細胞または軟骨細胞に分化する幹細胞を担持させることを特徴する多孔質基盤体の使用方法。
本発明における細胞を担持して培養することのできる多孔質基盤体は、主体と多孔質膜より構成される。
生体吸収性高分子としては、たとえば、ポリ乳酸、ポリグリコール酸、乳酸とグリコール酸の共重合体、ポリ−ε−カプロラクトン、これらの共重合体などのポリエステルあるいはセルロース、ポリアルギン酸などの多糖類等を挙げることができる。生体非吸収性高分子としては、ナイロン、ポリエチレン、ポリプロピレン、ポリスチレンなどを挙げることができる。中でも、本発明において好ましく使用される生体吸収性高分子は、たとえば、ポリ乳酸、乳酸とグリコール酸の共重合体、ポリ−ε−カプロラクトン、これらの共重合体で、生体非吸収高分子は、ナイロンである。
浸漬法は、生体吸収性天然高分子、細胞成長因子、細胞分化制御因子またはこれらの誘導体の水溶液の濃度や粘度が低い場合に有効であり、具体的には、生体吸収性天然高分子、細胞成長因子、細胞分化制御因子またはこれらの誘導体の低濃度水溶液に生体吸収性高分子、あるいは生体非吸収性高分子の多孔質体(メッシュ、スポンジなど)、あるいは多孔質円筒状体、あるいは多孔質直方体ないし立方体を浸漬することにより行われる。減圧脱気処理することにより、生体吸収性高分子、あるいは生体非吸収性高分子の多孔質体(メッシュ、スポンジなど)、あるいは多孔質円筒状体、あるいは多孔質直方体ないし立方体の中を生体吸収性天然高分子、細胞成長因子、細胞分化制御因子またはこれらの誘導体の低濃度水溶液で満たす。
この工程(2)では、第一の多孔質体(A)である生体吸収性合成高分子の多孔質体の上に第三の多孔質体(C)である生体吸収性合成高分子の多孔質体を載せて作製した多孔質体を前記生体吸収性天然高分子、細胞成長因子、細胞分化制御因子またはこれらの誘導体の水溶液で処理することができる。処理方法としては種々のものがあるが、浸漬法や塗布法が好ましく採用される。
上記工程(2)と(3)は上記図2aの場合と同様である。
例として、ポリエチレンシリンダーフレームとナイロンメッシュで作ったフレーム中に生体吸収性高分子である乳酸とグリコール酸との共重合体(PLGA)と生体吸収性天然高分子であるブタ皮膚由来ペプシン可溶化I型コラーゲンとの複合スポンジ(PLGA−コラーゲン複合スポンジ)部分とブタ皮膚由来ペプシン可溶化I型コラーゲンスポンジ部分より構成され、階層構造を有するPLGA−コラーゲン複合スポンジ/コラーゲンスポンジを導入した多孔質体を調製した。
例として、ポリエチレンシリンダーフレームとナイロンメッシュで作ったフレーム中に生体吸収性天然高分子であるウシI型アテロコラーゲンのスポンジを導入した多孔質体を調製した。
実施例2で調整した多孔質体を用いて、ヒト骨髄由来の間葉系幹細胞を担持させてなる軟骨組織の再生移植体の再構築を行った。
Claims (16)
- 細胞の播種用孔を有する多孔質基盤体であって、細胞の播種用孔を有する多孔質な主体の外周面に前記細胞よりも小さい孔からなる多孔質膜を配設してなることを特徴とする多孔質基盤体。
- 請求項1に記載の多孔質基盤体において、その主体が、フレーム状の骨格を有することを特徴とする多孔質基盤体。
- 請求項1に記載の多孔質基盤体において、その主体が、カゴ状の骨格を有することを特徴とする多孔質基盤体。
- 請求項1から3のいずれかに一項に記載の多孔質基盤体において、その多孔質膜は、生体吸収性物質又は生体非吸収性物質であることを特徴とする多孔質基盤体。
- 請求項1から4のいずれか一項に記載の多孔質基盤体において、その多孔質膜上に、さらに膜状多孔質体を積層してなることを特徴とする多孔質基盤体。
- 請求項5に記載の多孔質基盤体において、その膜状多孔質体が複数層繰り返して配設され、多層化されていることを特徴とする多孔質基盤体。
- 請求項3に記載の多孔質基盤体において、そのカゴ状主体中に、さらに多孔質物質を充填してなることを特徴とする多孔質基盤体。
- 請求項7に記載の多孔質基盤体において、その多孔質物質は、生体吸収性物質であることを特徴とする多孔質基盤体。
- 請求項4又は8に記載の多孔質基盤体において、その生体吸収性物質は、少なくとも生体吸収性合成高分子、生体吸収性天然高分子、細胞成長因子、細胞分化制御因子およびこれらの誘導体からなる群より選ばれる少なくとも1種よりなることを特徴とする多孔質基盤体。
- 請求項1から8のいずれか一項に記載の多孔質基盤体において、互いに異なる性質を有する層からなる複層構造を有することを特徴とする多孔質基盤体。
- 請求項10に記載の多孔質基盤体において、積層、包接、被覆、粒状もしくは塊状の接触、立体もしくは平面域のパターン接触、あるいはこれらの2種以上の組合せにより積層化されていることを特徴とする多孔質基盤体。
- 請求項10又は11に記載の多孔質基盤体において、複層構造を構成する各層は、組成、空隙率や孔の大きさや孔の連通性などの多孔質構造、および力学的性質のうちの少なくとも1種が互いに異なることを特徴とする多孔質基盤体。
- 請求項1から12のいずれか一項に記載の多孔質基盤体において、その主体が、生体吸収性合成高分子、生体吸収性天然高分子、細胞成長因子、細胞分化制御因子、およびこれらの誘導体からなる群から選ばれる少なくとも1種よりなることを特徴とする多孔質基盤体。
- 請求項10から12のいずれか一項に記載の多孔質基盤体において、複層構造の少くとも1層は、生体吸収性合成高分子、生体吸収性天然高分子、細胞成長因子、細胞分化制御因子、およびこれらの誘導体からなる群から選ばれる少なくとも1種よりなることを特徴とする多孔質基盤体。
- 請求項1から14のいずれか一項に記載の多孔質基盤体の製造方法であって、主体に骨格構造を有するものを用い、当該骨格構造の表面に多孔質膜を積層することを特徴とする多孔質基盤体の製造方法。
- 請求項1から14のいずれか一項に記載の多孔質基盤体の使用方法であって、その主体内に、軟骨細胞または軟骨細胞に分化する幹細胞を担持させることを特徴する多孔質基盤体の使用方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007536538A JP5540301B2 (ja) | 2005-09-20 | 2006-09-20 | 多孔質基盤体とその製造方法並びに多孔質基盤体の使用方法 |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005272429 | 2005-09-20 | ||
JP2005272429 | 2005-09-20 | ||
JP2005326719 | 2005-11-10 | ||
JP2005326719 | 2005-11-10 | ||
JP2005326720 | 2005-11-10 | ||
JP2005326720 | 2005-11-10 | ||
JP2007536538A JP5540301B2 (ja) | 2005-09-20 | 2006-09-20 | 多孔質基盤体とその製造方法並びに多孔質基盤体の使用方法 |
PCT/JP2006/318651 WO2007034843A1 (ja) | 2005-09-20 | 2006-09-20 | 多孔質基盤体とその製造方法並びに多孔質基盤体の使用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2007034843A1 true JPWO2007034843A1 (ja) | 2009-03-26 |
JP5540301B2 JP5540301B2 (ja) | 2014-07-02 |
Family
ID=37888886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007536538A Expired - Fee Related JP5540301B2 (ja) | 2005-09-20 | 2006-09-20 | 多孔質基盤体とその製造方法並びに多孔質基盤体の使用方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8673640B2 (ja) |
JP (1) | JP5540301B2 (ja) |
WO (1) | WO2007034843A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5187815B2 (ja) * | 2007-07-20 | 2013-04-24 | 独立行政法人物質・材料研究機構 | 透明材とその製造方法 |
JP5669248B2 (ja) * | 2007-10-18 | 2015-02-12 | 独立行政法人物質・材料研究機構 | 多孔質足場材 |
PL2408401T3 (pl) | 2009-03-03 | 2016-10-31 | Sposoby, urządzenia i układy dla inżynierii tkanki kostnej z wykorzystaniem bioreaktora | |
JP5557084B2 (ja) * | 2009-03-17 | 2014-07-23 | 独立行政法人物質・材料研究機構 | 組織再生方法 |
WO2018044699A1 (en) | 2016-08-27 | 2018-03-08 | 3D Biotek, Llc | Bioreactor |
KR102174112B1 (ko) * | 2017-04-07 | 2020-11-04 | 에피본, 인크. | 접종 및 배양용 시스템 및 방법 |
WO2024006421A1 (en) * | 2022-07-01 | 2024-01-04 | The Regents Of The University Of California | Method to direct vascularization of tissue grafts |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4803168A (en) * | 1983-09-01 | 1989-02-07 | Damon Biotech, Inc. | Microencapsulation with polymers |
WO1994003584A1 (en) * | 1992-08-07 | 1994-02-17 | Tissue Engineering, Inc. | Production of graft tissue from extracellular matrix |
US6689608B1 (en) * | 1993-02-01 | 2004-02-10 | Massachusetts Institute Of Technology | Porous biodegradable polymeric materials for cell transplantation |
US5916585A (en) | 1996-06-03 | 1999-06-29 | Gore Enterprise Holdings, Inc. | Materials and method for the immobilization of bioactive species onto biodegradable polymers |
US5972332A (en) * | 1997-04-16 | 1999-10-26 | The Regents Of The University Of Michigan | Wound treatment with keratinocytes on a solid support enclosed in a porous material |
US6214049B1 (en) * | 1999-01-14 | 2001-04-10 | Comfort Biomedical, Inc. | Method and apparatus for augmentating osteointegration of prosthetic implant devices |
US6143293A (en) * | 1998-03-26 | 2000-11-07 | Carnegie Mellon | Assembled scaffolds for three dimensional cell culturing and tissue generation |
US6328765B1 (en) * | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
JP3521226B2 (ja) | 2000-11-16 | 2004-04-19 | 独立行政法人産業技術総合研究所 | 架橋複合生体材料 |
JP3646162B2 (ja) | 2001-07-04 | 2005-05-11 | 独立行政法人産業技術総合研究所 | 軟骨組織の再生用移植体 |
WO2003018077A1 (fr) * | 2001-08-22 | 2003-03-06 | National Institute Of Advanced Industrial Science And Technology | Procede de regeneration osseuse |
US6790455B2 (en) * | 2001-09-14 | 2004-09-14 | The Research Foundation At State University Of New York | Cell delivery system comprising a fibrous matrix and cells |
JP3646167B2 (ja) * | 2002-02-19 | 2005-05-11 | 独立行政法人産業技術総合研究所 | フォスフォフォリンを含む複合生体材料 |
EP1500405B1 (en) * | 2002-05-01 | 2014-03-05 | Japan Science and Technology Agency | Method for preparing porous composite material |
-
2006
- 2006-09-20 WO PCT/JP2006/318651 patent/WO2007034843A1/ja active Application Filing
- 2006-09-20 US US11/992,216 patent/US8673640B2/en not_active Expired - Fee Related
- 2006-09-20 JP JP2007536538A patent/JP5540301B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20090233362A1 (en) | 2009-09-17 |
JP5540301B2 (ja) | 2014-07-02 |
WO2007034843A1 (ja) | 2007-03-29 |
US8673640B2 (en) | 2014-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1273312B1 (en) | Implant for cartilage tissue regeneration | |
Chang et al. | Cartilage tissue engineering on the surface of a novel gelatin–calcium‐phosphate biphasic scaffold in a double‐chamber bioreactor | |
JP4522686B2 (ja) | 組織フラグメントを伴う生体相容性の支持骨格装置 | |
JP4623954B2 (ja) | 靭帯または腱の修復用の生体相容性の支持骨格装置 | |
Park et al. | Injectable bone using chitosan-alginate gel/mesenchymal stem cells/BMP-2 composites | |
CN111714706B (zh) | 可促进血管细胞增殖和分泌细胞外基质的血管支架、血管支架的制备方法及活性人工血管 | |
JP5540301B2 (ja) | 多孔質基盤体とその製造方法並びに多孔質基盤体の使用方法 | |
US8748142B2 (en) | Culture of cardiovascular cells on a matrix and method for regenerating cardiovascular tissue | |
KR101135709B1 (ko) | 탈세포화된 세포외 기질을 이용한 줄기세포 이식용 고분자 지지체의 표면 개질 방법 | |
EP1835949A2 (en) | Tissue engineering devices for the repair and regeneration of tissue | |
CA2330104A1 (en) | Creation of three-dimensional tissues | |
JPH04501080A (ja) | 重合マトリックス上の大容量の細胞の移植方法 | |
US20060159665A1 (en) | Seed tear resistant scaffold | |
Risbud | Tissue engineering: implications in the treatment of organ and tissue defects | |
JP4412537B2 (ja) | 骨の再生方法 | |
JP4923235B2 (ja) | 骨−軟骨組織の再生用移植体 | |
JPWO2002045767A1 (ja) | 組織再生用基材、移植用材料及びそれらの製法 | |
JP4358621B2 (ja) | 細胞と細胞増殖因子とからなる腎臓の再生のための材料 | |
JP2005211477A (ja) | 再生医療用支持体 | |
JP2003245338A (ja) | 関節軟骨修復材 | |
Senköylü et al. | Interaction of cultured chondrocytes with chitosan scaffold | |
JP2001238900A (ja) | 心臓弁基材およびその製造方法、並びに心臓弁の再生方法 | |
JP5339323B2 (ja) | 多孔質体とその製造方法 | |
CN109876187B (zh) | 球状蛋白作致孔剂的组织工程软骨修复支架及其制备方法 | |
EO et al. | Comparative Study of Seeding andCulture Methods to Vascular SmoothMuscle Cells on Biodegradable Scaffold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090612 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090902 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120710 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120824 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130416 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130530 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20131203 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140128 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140204 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140401 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140409 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5540301 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |